RTW INVESTMENTS, LP - 31 Dec 2025 SCHEDULE 13G Report for Apellis Pharmaceuticals, Inc. Common Stock, $0.0001 par value (APLS)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- APLS
- Shares outstanding
- 125,684,656 shares
- Disclosed Ownership
- 7,666,764 shares
- Ownership
- 6.1%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 08:25:04 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 6.1% | 7,666,764 | 0 | 7,666,764 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong | 6.1% | 7,666,764 | 0 | 7,666,764 | s/ Roderick Wong, M.D. | Roderick Wong, M.D. |